84年鼠女哪年财运最旺,857comvvv色九欧美激情|85PO_87国产精品欲av国产av资源

[1]徐展望,李念虎.柚皮苷對(duì)體外培養(yǎng)骨髓間充質(zhì)干細(xì)胞Runx-2和 Osterix表達(dá)及骨質(zhì)疏松模型大鼠骨強(qiáng)度的影響[J].中醫(yī)正骨,2013,25(12):7-10.
　Xu Zhanwang*,Li Nianhu.*.Effect of naringin on expression of Runx-2 and Osterix in bone marrow stem cell cultured in vitro and on bone strength for osteoporosis rat model[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(12):7-10.
點(diǎn)擊復(fù)制

柚皮苷對(duì)體外培養(yǎng)骨髓間充質(zhì)干細(xì)胞Runx-2和 Osterix表達(dá)及骨質(zhì)疏松模型大鼠骨強(qiáng)度的影響()
分享到：

《中醫(yī)正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第25卷
期數(shù):
2013年12期
頁(yè)碼:
7-10
欄目:
骨質(zhì)疏松癥
出版日期:
2013-12-30

文章信息/Info

Title:
Effect of naringin on expression of Runx-2 and Osterix in bone marrow stem cell cultured in vitro and on bone strength for osteoporosis rat model
作者:
徐展望; 李念虎
山東中醫(yī)藥大學(xué)附屬醫(yī)院,山東 濟(jì)南 250014
Author(s):
Xu Zhanwang*; Li Nianhu.*
The Affiliated Hospital of Shandong University of Traditional Chinese Medicine,Jinan 250014,Shangdong,China
關(guān)鍵詞:
骨質(zhì)疏松 柚皮苷 骨碎補(bǔ) 骨髓間充質(zhì)干細(xì)胞 Runt相關(guān)轉(zhuǎn)錄因子2 Osterix 生物力學(xué) 動(dòng)物實(shí)驗(yàn)
Keywords:
Osteoporosis;  Naringin;  Drynaria fortunei;  Bone marrow stem cell;  Runt-related transcription factor 2;  Osterix;  Biomechanics;  Animal experimentation
摘要:
目的:探討柚皮苷對(duì)體外培養(yǎng)骨髓間充質(zhì)干細(xì)胞Runx-2和Osterix表達(dá)及骨質(zhì)疏松模型大鼠骨強(qiáng)度的作用。方法:采用髓腔沖洗離心法從雌性Lewis大鼠股骨獲取骨髓間充質(zhì)干細(xì)胞,將傳代培養(yǎng)后的細(xì)胞分為5組。A組不進(jìn)行干預(yù),B組加入二甲基亞砜,C、D、E組分別加入濃度為1 μg·mL-1、10 μg·mL-1、100 μg·mL-1的柚皮苷。培養(yǎng)6 h后收集細(xì)胞采用RT-PCR法測(cè)定各組細(xì)胞Runx-2和Osterix的mRNA表達(dá)水平。將24只雌性SD大鼠的卵巢切除,3個(gè)月后將其隨機(jī)分為4組,每組6只。Ⅰ組、Ⅱ組、Ⅲ組分別以60 mg·kg-1、300 mg·kg-1和1 500 mg·kg-1柚皮苷灌胃,Ⅳ組給予等體積的PBS灌胃,每天灌胃1次,持續(xù)2個(gè)月。藥物干預(yù)結(jié)束后,測(cè)定大鼠股骨強(qiáng)度和脛骨骨小梁面積。結(jié)果:①Runx-2 mRNA和Osterix mRNA表達(dá)水平。B、C、D、E組大鼠骨髓間充質(zhì)干細(xì)胞Runx-2 mRNA表達(dá)水平比較,差異有統(tǒng)計(jì)學(xué)意義[(1.10±0.02),(2.05±0.31),(2.76±0.14),(1.82±0.10),F=44.021,P=0.000]。進(jìn)一步兩兩比較,C、D、E組Runx-2 mRNA表達(dá)水平高于B組(P=0.000,P=0.000,P=0.000); D組高于C組和E組(P=0.001,P=0.000); C組和E組比較,差異無(wú)統(tǒng)計(jì)學(xué)意義(P=0.153)。B、C、D、E組Osterix mRNA表達(dá)水平比較,差異有統(tǒng)計(jì)學(xué)意義[(1.02±0.10),(1.11±1.35),(3.24±0.30),(2.55±0.35),F=7.037,P=0.012]。進(jìn)一步兩兩比較,D組和E組Osterix mRNA表達(dá)水平高于B組(P=0.031,P=0.005); C組和B組比較,差異無(wú)統(tǒng)計(jì)學(xué)意義(P=0.886); C組低于D組和E組(P=0.006,P=0.039); D組和E組比較,差異無(wú)統(tǒng)計(jì)學(xué)意義(P=0.267)。②股骨生物力學(xué)強(qiáng)度。4組骨質(zhì)疏松模型大鼠股骨強(qiáng)度比較,差異有統(tǒng)計(jì)學(xué)意義[(773.36±9.21)N·mm-1,(805.66±16.00)N·mm-1,(766.70±38.96)N·mm-1,(707.46±15.88)N·mm-1,F=37.776,P=0.000]。進(jìn)一步兩兩比較,Ⅰ、Ⅱ、Ⅲ組股骨強(qiáng)度均高于Ⅳ組(P=0.000,P=0.000,P=0.000); Ⅰ組和Ⅲ組比較,差異無(wú)統(tǒng)計(jì)學(xué)意義(P=0.509); Ⅱ組高于Ⅰ組和Ⅲ組(P=0.004,P=0.001)。③脛骨骨小梁面積。4組骨質(zhì)疏松模型大鼠脛骨骨小梁面積比較,差異有統(tǒng)計(jì)學(xué)意義[(22.26±2.32),(25.10±2.18),(23.66±3.26),(15.63±2.00),F=14.168,P=0.000]。進(jìn)一步兩兩比較,Ⅰ、Ⅱ、Ⅲ組脛骨骨小梁面積均大于Ⅳ組(P=0.001,P=0.000,P=0.000); Ⅰ組與Ⅱ組和Ⅲ組比較,差異均無(wú)統(tǒng)計(jì)學(xué)意義(P=0.090,P=0.387); Ⅱ組和Ⅲ組比較,差異無(wú)統(tǒng)計(jì)學(xué)意義(P=0.374)。結(jié)論:柚皮苷可促進(jìn)體外培養(yǎng)的骨髓間充質(zhì)干細(xì)胞中Runx-2和Osterix的表達(dá),增強(qiáng)骨質(zhì)疏松模型大鼠的骨強(qiáng)度,增大骨小梁面積。
Abstract:
Objective:To explore the effect of naringin on the expression of Runx-2 and Osterix in bone marrow stem cell(BMSC)cultured in vitro and on the bone strength for osteoporosis rat model.Methods:The BMSC were obtained from femur of femina Lewis rats by medullary cavity flushing and centrifugation,and the cells were divided into 5 groups after serial subcultivation.The cells in group A were not intervened and the cells in group B were placed in the culture fluids supplemented with dimethyl sulfoxide,while cells in other groups were placed in the culture fluids respectively supplemented with naringin with final concentration of 1 μg/mL(group C),10 μg/mL(group D)and 100 μg/mL(group E).The expression level of Runx-2 mRNA and Osterix mRNA were detected through RT-PCR after 6-hour culture.Twenty-four female SD rats were administrated with ovariectomy to creat models of osteoporosis and were randomly divided into 4 groups 3 months later,6 cases in each group.The rats in groupⅠ,Ⅱand Ⅲ were intragastric administrated with naringin with dose of 60 mg/kg(groupⅠ),300 mg/kg(groupⅡ)and 1 500 mg/kg(groupⅢ),while the rats in group Ⅳ were intragastric administrated with PBS, once a day for consecutive 2 months.After the drug intervention,the femur strength and the tibia trabecular bone area of the rats were measured.Results:There were statistical differences in Runx-2 mRNA expression level of BMSC among group B,C,D and E((1.10+/-0.02),(2.05+/-0.31),(2.76+/-0.14),(1.82+/-0.10),F=44.021,P=0.000).Further pairwise comparison showed that the Runx-2 mRNA expression level of group C,D and E were higher than that of group B(P=0.000,P=0.000,P=0.000),and group D surpassed group C and E(P=0.001,P=0.000),and there was no statistical difference between group C and group E(P=0.153).There were statistical differences in Osterix mRNA expression level of BMSC among group B,C,D and E((1.02+/-0.10),(1.11+/-1.35),(3.24+/-0.30),(2.55+/-0.35),F=7.037,P=0.012).Further pairwise comparison showed that the Osterix mRNA expression level of group D and group E were higher than that of group B(P=0.031,P=0.005),and there was no statistical difference between group C and group B(P=0.886),and the Osterix mRNA expression level of group C were lower than that of group D and group E(P=0.006,P=0.039),and there was no statistical difference between group D and group E(P=0.267).There were statistical differences in the femur strength among groupsⅠ,Ⅱ,ⅢandⅣ((773.36+/-9.21),(805.66+/-16.00),(766.70+/-38.96),(707.46+/-15.88)N/mm,F=37.776,P=0.000).Further pairwise comparison showed that the femur strength of groupⅠ,Ⅱand Ⅲ were higher than that of group Ⅳ(P=0.000,P=0.000,P=0.000),and there was no statistical difference between groupⅠand group Ⅲ(P=0.509),and the femur strength of group Ⅱ were higher than that of groupⅠand group Ⅲ(P=0.004,P=0.001).There were statistical differences in the tibial bone trabecula area among groupⅠ,Ⅱ,Ⅲ and Ⅳ((22.26+/-2.32),(25.10+/-2.18),(23.66+/-3.26),(15.63+/-2.00),F=14.168,P=0.000).Further pairwise comparison showed that the tibial bone trabecula area of groupⅠ,Ⅱand Ⅲ were larger than that of group Ⅳ(P=0.001,P=0.000,P=0.000),and there were no statistical differences among groupⅠ,Ⅱand Ⅲ(P=0.090,P=0.387),and there was no statistical difference between groupⅡand group Ⅲ(P=0.374).Conclusion:Naringin can promote the expression of Runx-2 and Osterix in BMSC cultured in vitro,and it can increase bone strength and bone trabecula area of osteoporosis rat.

參考文獻(xiàn)/References:

[1] Melton LJ 3rd.How many women have osteoporosis now?[J].J Bone Miner Res,1995,10(2):175-177.
[2] Zimmermann EA,Schaible E,Bale H,et al.Age-related changes in the plasticity and toughness of human cortical bone at multiple length scales[J].Proc Natl Acad Sci U S A,2011,108(35):14416-14421.
[3] 李彬,張柳.RUNX2與骨代謝的調(diào)控[J].中國(guó)骨質(zhì)疏松雜志,2009,15(1):63-67.
[4] Cao Y,Zhou Z,de Crombrugghe B,et al.Osterix,a transcription factor for osteoblast differentiation,mediates antitumor activity in murine osteosarcoma[J].Cancer Res,2005,65(4):1124-1128.
[5] Nakashima K,Zhou X,Kunkel G,et al.The novel Zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation[J].Cell,2002,108(1):17-29.
[6] Ramesh N,Viswanathan MB,Saraswathy A,et al.Phytochemical and antimicrobial studies on Drynaria quercifolia[J].Fitoterapia,2001,72(8):934-936.
[7] Li N,Jiang Y,Wooley PH,et al.Naringin promotes osteoblast differentiation and effectively reverses ovariectomy-associated osteoporosis[J].J Orthop Sci,2013,18(3):478-485.
[8] Yu H,VandeVord PJ,Mao L,et al.Improved tissue-engineered bone regeneration by endothelial cell mediated vascularization[J].Biomaterials,2009,30(4):508-517.
[9] Wu JB,Fong YC,Tsai HY,et al.Naringin-induced bone morphogenetic protein-2 expression via PI3K,Akt,c-Fos/c-Jun and AP-1 pathway in osteoblasts[J].Eur J Pharmacol,2008,588(2-3):333-341.
[10] Ang ES,Yang X,Chen H,et al.Naringin abrogates osteoclastogenesis and bone resorption via the inhibition of RANKL-induced NF-κB and ERK activation[J].FEBS Lett,2011,585(17):2755-2762.
[11] McCarthy TL,Centrella M.Novel links among Wnt and TGF-beta signaling and Runx2[J].Mol Endocrinol,2010,24(3):587-597.
[12] Zhang C,Cho K,Huang Y,et al.Inhibition of Wnt signaling by the osteoblast-specific transcription factor Osterix[J].Proc Natl Acad Sci U S A,2008,105(19):6936-6941.

備注/Memo

備注/Memo:
2013-09-15收稿 2013-11-01修回
基金項(xiàng)目:山東省自然科學(xué)基金面上項(xiàng)目(Y2008C147)
通訊作者:徐展望 E-mail:[email protected]
更新日期/Last Update: 2013-12-30